Pillarisetti; Kodandaram
Patent Applications and Registrations
Patent applications and USPTO patent grants for Pillarisetti; Kodandaram.The latest application filed is for "trispecific antibody targeting bcma, gprc5d, and cd3".
- Pillarisetti; Kodandaram - King of Prussia PA
- Pillarisetti; Kodandaram - Spring House PA
| Patent | Date |
|---|---|
| Trispecific Antibody Targeting Bcma, Gprc5d, And Cd3 App 20220267438 - Attar; Ricardo Marcos ; et al. | 2022-08-25 |
| Methods For Treating Multiple Myeloma App 20220177584 - Girgis; Suzette ; et al. | 2022-06-09 |
| Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof Grant 10,562,968 - Attar , et al. Feb | 2020-02-18 |
| Anti-BCMA antibodies and uses thereof Grant 10,072,088 - Pillarisetti , et al. September 11, 2 | 2018-09-11 |
| Anti- Gprc5d Antibodies, Bispecific Antigen Binding Molecules That Bind Gprc5d And Cd3, And Uses Thereof App 20180037651 - Attar; Ricardo ; et al. | 2018-02-08 |
| Anti-BCMA Antibodies, Bispecific Antigen Binding Molecules that Bind BCMA and CD3, and Uses Thereof App 20170051068 - Pillarisetti; Kodandaram ; et al. | 2017-02-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 